Healthcare | March 02, 2026
Zenex Animal Health makes strategic European play with VievePharm acquisition
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
Inspection included drug device combinations covering our recent filing in nasal sprays domain
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
The Ma’anshan site approval covers pastilles, oral liquids, and powders
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Subscribe To Our Newsletter & Stay Updated
